Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Arbele Limited
National Cancer Institute (NCI)
Seagen Inc.
Centre of Postgraduate Medical Education
Sanofi
Bristol-Myers Squibb
PAVmed Inc.
University Hospital Heidelberg
Seagen Inc.
CancerCare Manitoba
University of Oxford
Ludwig Institute for Cancer Research
Jules Bordet Institute
Rigshospitalet, Denmark
City of Hope Medical Center
Hoosier Cancer Research Network
Istituto Oncologico Veneto IRCCS
Dana-Farber Cancer Institute
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
PAVmed Inc.
Mayo Clinic
Columbia University
Fox Chase Cancer Center
Novartis
MacroGenics
Mayo Clinic
Columbia University
Translational Oncology Research International
Alliance for Clinical Trials in Oncology
Johns Hopkins University
Rigshospitalet, Denmark
AIO-Studien-gGmbH
UNICANCER
OHSU Knight Cancer Institute
Swiss Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Federation Francophone de Cancerologie Digestive
Lund University Hospital
Karolinska University Hospital
SWOG Cancer Research Network
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Northwestern University
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology